Björg Ásbjörnsdóttir

664 total citations · 1 hit paper
29 papers, 443 citations indexed

About

Björg Ásbjörnsdóttir is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Björg Ásbjörnsdóttir has authored 29 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Obstetrics and Gynecology, 14 papers in Pediatrics, Perinatology and Child Health and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Björg Ásbjörnsdóttir's work include Gestational Diabetes Research and Management (19 papers), Pregnancy and preeclampsia studies (14 papers) and Birth, Development, and Health (12 papers). Björg Ásbjörnsdóttir is often cited by papers focused on Gestational Diabetes Research and Management (19 papers), Pregnancy and preeclampsia studies (14 papers) and Birth, Development, and Health (12 papers). Björg Ásbjörnsdóttir collaborates with scholars based in Denmark, United States and Canada. Björg Ásbjörnsdóttir's co-authors include Elisabeth R. Mathiesen, Peter Damm, Lene Ringholm, Marianne Vestgaard, Harpreet S. Bajaj, Julio Rosenstock, Chantal Mathieu, Wendy Lane, Sreenivasa Murthy and Dorte Møller Jensen and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Björg Ásbjörnsdóttir

28 papers receiving 434 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial

2023 86 citations Chantal Mathieu, Björg Ásbjörnsdóttir et al. The Lancet profile →

Peers

Countries citing papers authored by Björg Ásbjörnsdóttir

Since Specialization

Citations

This map shows the geographic impact of Björg Ásbjörnsdóttir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björg Ásbjörnsdóttir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björg Ásbjörnsdóttir more than expected).

Fields of papers citing papers by Björg Ásbjörnsdóttir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björg Ásbjörnsdóttir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björg Ásbjörnsdóttir. The network helps show where Björg Ásbjörnsdóttir may publish in the future.

Co-authorship network of co-authors of Björg Ásbjörnsdóttir

This figure shows the co-authorship network connecting the top 25 collaborators of Björg Ásbjörnsdóttir. A scholar is included among the top collaborators of Björg Ásbjörnsdóttir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björg Ásbjörnsdóttir. Björg Ásbjörnsdóttir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic Properties of Once‐Weekly Insulin Icodec in Children and Adolescents With Type 2 Diabetes 2025 ·Pediatric Diabetes ·Michelle Van Name, Björg Ásbjörnsdóttir, Marília Brito Gomes, Paula M. Hale, K. N. Udupa, (unknown), Risa M. Wolf, Rasmus Ribel‐Madsen	1
2	Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials 2024 ·Diabetes Obesity and Metabolism ·Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Tanvir Johanning Bari, Kamilla Begtrup, Tina Vilsbøll, Julio Rosenstock	9
3	Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4 2024 ·Diabetes Care ·Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, (unknown), Chantal Mathieu, Athena Philis‐Tsimikas, Tadej Battelino	11
4	Pharmacokinetic/Pharmacodynamic Modeling of Efficacy and Hypoglycemia Rate When Switching From Once-Daily Basal Insulin to Once-Weekly Insulin Icodec Without or With a One-Time Additional Dose in Insulin-Experienced Individuals With Type 2 Diabetes 2024 ·Endocrine Practice ·Ildiko Lingvay, Björg Ásbjörnsdóttir, Niels Rode Kristensen, (unknown), André Gustavo Daher Vianna, Filip K. Knop	2
5	Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1 2024 ·The Lancet Diabetes & Endocrinology ·Richard M. Bergenstal, Björg Ásbjörnsdóttir, Sara Kehlet Watt, Ildiko Lingvay, Julia K. Mader, Tomoyuki Nishida, Julio Rosenstock	5
6	Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial breakdown → 2023 ·The Lancet ·Chantal Mathieu, Björg Ásbjörnsdóttir, Harpreet S. Bajaj, Wendy Lane, (unknown), Sreenivasa Murthy, (unknown), Julio Rosenstock	86
7	Falling Insulin Requirement in Pregnant Women With Diabetes Delivering Preterm: Prevalence, Predictors, and Consequences 2022 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), (unknown), Marianne Vestgaard, Björg Ásbjörnsdóttir, (unknown), (unknown), Lone Storgaard, Birgitte Nielsen, Pernille Holmager, Lene Ringholm, Peter Damm, Elisabeth R. Mathiesen	3
8	The impact of anti‐hypertensive treatment on foetal growth and haemodynamics in pregnant women with pre‐existing diabetes – An explorative study 2021 ·Diabetic Medicine ·Marianne Vestgaard, (unknown), Björg Ásbjörnsdóttir, Lone Nikoline Nørgaard, (unknown), C. K. Ekelund, Lene Ringholm, Lise Lotte Torvin Andersen, Dorte Møller Jensen, Ann Tabor, Peter Damm, Elisabeth R. Mathiesen	0
9	Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes 2021 ·Diabetologia ·(unknown), Marianne Vestgaard, Björg Ásbjörnsdóttir, (unknown), (unknown), Lone Storgaard, Birgitte Nielsen, Lene Ringholm, Peter Damm, Elisabeth R. Mathiesen	18
10	946-P: Unchanged Prevalence of Preeclampsia after Implementation of Prophylactic Aspirin to All Pregnant Women with Preexisting Diabetes: A Prospective Cohort Study 2021 ·Diabetes ·(unknown), Marianne Vestgaard, Björg Ásbjörnsdóttir, (unknown), Lene Ringholm, Lise Lotte Torvin Andersen, Dorte Møller Jensen, Peter Damm, Elisabeth R. Mathiesen	1
11	Predictors of emergency cesarean section in women with preexisting diabetes 2020 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·Margit Bistrup Fischer, Marianne Vestgaard, Björg Ásbjörnsdóttir, Elisabeth R. Mathiesen, Peter Damm	10
12	Dietary intake of carbohydrates in pregnant women with type 1 diabetes—A narrative review 2020 ·Food Science & Nutrition ·(unknown), Björg Ásbjörnsdóttir, Inge Tetens, Anni Larnkjær, Christian Mølgaard, Elisabeth R. Mathiesen	9
13	Routine use of antenatal nonstress tests in pregnant women with diabetes–What is the practice? 2020 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), Marianne Vestgaard, Björg Ásbjörnsdóttir, Elisabeth R. Mathiesen, Peter Damm	1
14	White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes 2019 ·Diabetologia ·Marianne Vestgaard, Björg Ásbjörnsdóttir, Lene Ringholm, Lise Lotte Torvin Andersen, Dorte Møller Jensen, Peter Damm, Elisabeth R. Mathiesen	15
15	Lower daily carbohydrate consumption than recommended by the Institute of Medicine is common among women with type 2 diabetes in early pregnancy in Denmark 2019 ·Diabetes Research and Clinical Practice ·Björg Ásbjörnsdóttir, (unknown), Marianne Vestgaard, Lene Ringholm, (unknown), Dorte Møller Jensen, Anne Raben, Peter Damm, Elisabeth R. Mathiesen	10
16	Effect of motivational interviewing on gestational weight gain and fetal growth in pregnant women with type 2 diabetes 2019 ·BMJ Open Diabetes Research & Care ·Björg Ásbjörnsdóttir, Marianne Vestgaard, Lene Ringholm, Lise Lotte Torvin Andersen, Dorte Møller Jensen, Peter Damm, Elisabeth R. Mathiesen	17
17	Home blood pressure in pregnancy–the upper reference limit 2019 ·Blood Pressure Monitoring ·Marianne Vestgaard, (unknown), (unknown), Björg Ásbjörnsdóttir, Lene Ringholm, Peter Damm, Elisabeth R. Mathiesen	11
18	Physical activity, sedentary behavior and development of preeclampsia in women with preexisting diabetes 2019 ·Acta Diabetologica ·(unknown), Marianne Vestgaard, Björg Ásbjörnsdóttir, (unknown), Lene Ringholm, Lise Lotte Torvin Andersen, Dorte Møller Jensen, Peter Damm, Elisabeth R. Mathiesen	5
19	Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes 2018 ·Diabetes Research and Clinical Practice ·(unknown), Marianne Vestgaard, (unknown), Björg Ásbjörnsdóttir, Lene Ringholm, David McIntyre, Peter Damm, Elisabeth R. Mathiesen	32
20	The influence of carbohydrate consumption on glycemic control in pregnant women with type 1 diabetes 2016 ·Diabetes Research and Clinical Practice ·Björg Ásbjörnsdóttir, (unknown), (unknown), (unknown), Jens Rikardt Andersen, Peter Damm, Elisabeth R. Mathiesen	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact